By screening differentially expressed genes, and performing WGCNA, LASSO, and multivariate Cox regression analyses, we identified risk hub genes (RAB42, SH2D4A, and GDF15) associated with glioma stemness, genomic heterogeneity, and the immune microenvironment. This evidence concerns the gene RAB42 and glioma.